Tacrine

ADVERTISEMENT

Identification

Molecular formula
C13H14N2
CAS Number
321-64-2
IUPAC Name
1-piperidyl(1,2,3,4-tetrahydroacridin-9-yl)methanone
Molecular Weight
198.27g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3140g/cm3
Synonyms
BRN 0419592
Interesting facts

Interesting Facts About 1-Piperidyl(1,2,3,4-tetrahydroacridin-9-yl)methanone

1-Piperidyl(1,2,3,4-tetrahydroacridin-9-yl)methanone is a compound that has attracted attention for its potential applications in the fields of medicinal chemistry and neuroscience. Here are some fascinating insights:

  • Novel Structure: This compound features a unique fusion of a piperidine ring and a tetrahydroacridine moiety, making it an interesting candidate for exploring structure-activity relationships.
  • Potential Therapeutic Uses: Researchers are investigating its implications as a pharmacological agent. Its structure suggests possible effects on neurotransmitter systems, particularly in relation to acetylcholine and dopamine, which can be crucial in treating cognitive disorders.
  • Neuroprotective Properties: Compounds related to tetrahydroacridine are often studied for neuroprotective effects. This compound may exhibit such properties and is being evaluated for its potential in neurodegenerative diseases.
  • Research Interest: Due to its complex structure, scientists are conducting synthetic studies to develop analogs that can enhance its bioactivity and selectivity, aiming for lower side effects in therapeutic applications.
  • Medicinal Chemistry: As a promising lead compound, it serves as a blueprint for developing new drugs targeting cognitive impairments and other neurological disorders.

In conclusion, 1-piperidyl(1,2,3,4-tetrahydroacridin-9-yl)methanone is more than just a compound; it represents a growing field of research aimed at unlocking novel treatments for complex brain disorders. As a scientist or chemistry student, it’s exciting to see how compounds like this shape the future of drug discovery and development.

ADVERTISEMENT